USP34

USP34

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">USP34</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">N-terminal region</td>
<td>Regulatory domains, protein interactions</td>
</tr>
<tr>
<td class="label">USP catalytic domain</td>
<td>Cysteine protease activity</td>
</tr>
<tr>
<td class="label">C-terminal region</td>
<td>Substrate recognition, localization</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Double-strand break repair</td>
<td>Regulates repair protein recruitment</td>
</tr>
<tr>
<td class="label">Checkpoint activation</td>
<td>Modulates checkpoint kinases</td>
</tr>
<tr>
<td class="label">Replication stress</td>
<td>Handles stalled replication forks</td>
</tr>
<tr>
<td class="label">Chromatin remodeling</td>
<td>Interacts with histone modifiers</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Direct DUB inhibition</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Modulate expression</td>
</tr>
<tr>
<td class="label">Pathway modulators</td>
<td>Target upstream regulators</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">β-catenin</td>
<td>Wnt</td>
</tr>
<tr>
<td class="label">BRCA1</td>
<td>DNA rep

USP34

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">USP34</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Function</td>
</tr>
<tr>
<td class="label">N-terminal region</td>
<td>Regulatory domains, protein interactions</td>
</tr>
<tr>
<td class="label">USP catalytic domain</td>
<td>Cysteine protease activity</td>
</tr>
<tr>
<td class="label">C-terminal region</td>
<td>Substrate recognition, localization</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Double-strand break repair</td>
<td>Regulates repair protein recruitment</td>
</tr>
<tr>
<td class="label">Checkpoint activation</td>
<td>Modulates checkpoint kinases</td>
</tr>
<tr>
<td class="label">Replication stress</td>
<td>Handles stalled replication forks</td>
</tr>
<tr>
<td class="label">Chromatin remodeling</td>
<td>Interacts with histone modifiers</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Direct DUB inhibition</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Modulate expression</td>
</tr>
<tr>
<td class="label">Pathway modulators</td>
<td>Target upstream regulators</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">β-catenin</td>
<td>Wnt</td>
</tr>
<tr>
<td class="label">BRCA1</td>
<td>DNA repair</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Stress response</td>
</tr>
<tr>
<td class="label">Various DUBs</td>
<td>Proteostasis</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

USP34 (Ubiquitin Specific Peptidase 34) is a large deubiquitinating enzyme (DUB) that plays critical roles in regulating protein stability, signal transduction, and cellular homeostasis. Located on chromosome 2p16.3 with NCBI Gene ID 9736, USP34 is a member of the ubiquitin-specific protease family that catalyzes the removal of ubiquitin from substrate proteins. This activity is essential for modulating protein degradation, signal pathway activity, DNA repair, and numerous other cellular processes[@Komander2009].

USP34 has emerged as an important player in neurodegenerative disease pathogenesis due to its involvement in protein quality control mechanisms. The ubiquitin-proteasome system (UPS) is critical for clearing misfolded and aggregated proteins, and USP34 contributes to this process by regulating the ubiquitination status of substrates. Alterations in USP34 expression or function have been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS)[@Zhang2017].

Molecular Structure and Function

Protein Architecture

USP34 is a ~1,920 amino acid protein (~220 kDa) with the typical USP domain organization:

The catalytic domain contains the characteristic Cys-His-Asp catalytic triad that mediates deubiquitination activity. USP34 can cleave various ubiquitin chain linkages, including K48, K63, and K27, allowing it to regulate diverse cellular processes[@Kim2019].

Catalytic Mechanism

USP34 catalyzes deubiquitination through:

This mechanism allows USP34 to remove ubiquitin chains from substrates, preventing their degradation or altering their signaling functions.

Biological Functions

Wnt Signaling Pathway

USP34 plays a major role in regulating β-catenin stability in the Wnt pathway[@Mevius2019]:

• β-catenin stabilization: USP34 removes K48-linked ubiquitin from β-catenin
• Transcriptional activation: Accumulated β-catenin enters nucleus
• TCF/LEF target genes: Activates proliferation and development genes
• Development: Critical for embryonic development and tissue homeostasis

DNA Damage Response

USP34 is essential for genome stability[@Fang2018]:

Protein Quality Control

In the ubiquitin-proteasome system[@Clague2012]:

• Protein turnover: Regulates degradation of specific substrates
• Aggregate clearance: May assist in clearance of aggregation-prone proteins
• Quality control: Removes misfolded protein ubiquitin tags

Role in the Nervous System

Neuronal Expression

USP34 is expressed throughout the brain:

• Cerebral cortex: Pyramidal neurons, interneurons
• Hippocampus: CA1-CA3 pyramidal cells, dentate granule cells
• Striatum: Medium spiny neurons
• Cerebellum: Purkinje cells, granule cells

Synaptic Function

USP34 contributes to synaptic biology:

Protein Homeostasis

USP34 supports neuronal proteostasis:

• Aggregate prevention: May prevent toxic protein aggregation
• Clearance pathways: Supports autophagic and proteasomal clearance
• Stress response: Activates under cellular stress conditions

Disease Associations

Alzheimer's Disease

USP34 connections to AD include[@Todi2010]:

Parkinson's Disease

USP34 may contribute to PD through:

Amyotrophic Lateral Sclerosis

Genetic evidence links USP34 to ALS[@Zhang2017]:

• Rare variants: Associated with increased ALS risk
• Protein aggregation: May affect TDP-43 aggregation
• Motor neuron vulnerability: Critical for motor neuron survival
• Stress granule dynamics: Regulates stress granule function

Other Neurodegenerative Conditions

• Huntington's disease: May modulate mutant huntingtin clearance
• Frontotemporal dementia: Connections to protein homeostasis
• Spinocerebellar ataxia: Roles in cerebellar degeneration

Therapeutic Implications

Targeting USP34

Therapeutic strategies for modulating USP34:

Challenges

• Specificity: Achieving selective USP34 targeting
• Delivery: Brain-penetrant delivery
• Function complexity: Multiple pathway involvement

Interaction Network

USP34 interacts with multiple proteins:

Research Directions

Unresolved Questions

Emerging Areas

• Proteomics: Global identification of ubiquitinated substrates
• Structural studies: High-resolution USP34 structure
• Patient models: iPSC-derived neurons with USP34 variants

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
• [Wnt Signaling](/mechanisms/wnt-signaling)
• [DNA Repair](/mechanisms/dna-repair)
• [Protein Quality Control](/mechanisms/protein-quality-control-network)
• [USP34 Protein](/proteins/usp34-protein)

External Links

• [Ensembl: ENSG00000119147](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000119147)
• [UniProt: Q70EL2](https://www.uniprot.org/uniprot/Q70EL2)
• [GeneCards: USP34](https://www.genecards.org/cgi-bin/carddisp.pl?gene=USP34)
• [OMIM: 607267](https://www.omim.org/entry/607267)
• [NCBI Gene: 9736](https://www.ncbi.nlm.nih.gov/gene/9736)

References